Albany Molecular Research, Inc. to Announce Fourth Quarter 2002 Results.

Business Editors

ALBANY, N.Y.--(BUSINESS WIRE)--Jan. 28, 2003

Albany Molecular Research, Inc. (Nasdaq: AMRI) will report fourth quarter results before the opening of the market on Tuesday, February 11, 2003. The company will hold a conference call at 10:00 a.m. Eastern Time to discuss its quarterly financial results and business highlights. In addition, the company may answer questions concerning business and financial developments and trends, as well as other business and financial matters affecting the company.

If you are interested in listening to the conference call, please dial 800-450-0818 (for domestic calls) or 612-332-0345 (for international calls) at 9:45 a.m. and reference the AMRI Fourth Quarter 2002 Earnings Release conference call. Replays of the call will be available for seven days following the call beginning at 3:15 p.m. on February 11, 2003. To access the replay by telephone, please call 800-475-6701 (for domestic calls) or 320-365-3844 (for international calls) and use access code #673432.

Albany Molecular Research, Inc. is a leading research, drug discovery and development company built on a chemistry platform of comprehensive and integrated technologies, resources and capabilities. The company conducts pharmaceutical research and development with many leading pharmaceutical and biotechnology companies and for its own internal discovery programs.